NCT04599608View on ClinicalTrials.gov

Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients

Not yet recruitingOBSERVATIONAL

Enrollment

248

Participants

Timeline

Start Date

February 28, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

January 31, 2026

Conditions

Advanced CancerMetastatic Cancer

Sponsors

Collaborators (1)

Curesponse Ltd.

All Listed Sponsors

collaborator

Curesponse Ltd.

UNKNOWN

lead

Imperial College London

OTHER

NCT04599608 - Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients | Biotech Hunter | Biotech Hunter